Related references
Note: Only part of the references are listed.Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: A single-dose, crossover pharmacokinetic study
Suma Krishnan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study
Joseph Biederman et al.
BIOLOGICAL PSYCHIATRY (2007)
Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth
Stephen V. Faraone et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
Joseph Biederman et al.
CLINICAL THERAPEUTICS (2007)
History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs
Charles R. Schuster
DRUG AND ALCOHOL DEPENDENCE (2006)
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate
TJ Spencer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Attention-deficit hyperactivity disorder
J Biederman et al.
LANCET (2005)
The neuropsychopharmacology of attention-deficit/hyperactivity disorder
SR Pliszka
BIOLOGICAL PSYCHIATRY (2005)
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: Data from the first 1000 STEP-BD participants
AA Nierenberg et al.
BIOLOGICAL PSYCHIATRY (2005)
New formulations of stimulants for attention-deficit hyperactivity disorder - Therapeutic potential
DF Connor et al.
CNS DRUGS (2004)
Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention
JK Buitelaar et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall
JJ McGough et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2003)
Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder proof-of-concept and proof-of-product studies
J Swanson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD
ND Volkow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
TE Wilens et al.
PEDIATRICS (2003)
Share Paper
